1858-1859 / 2001
The San Diego experience
•
Int J Radiat Oncol Biol Phys.
2013 Jun 1;86(2):324-9.
•
Salvage HDR brachytherapy for recurrent prostate cancer
after previous definitive radiation therapy: 5-year outcomes.
•
Chen CP
1
Weinberg V Shinohara K Roach M 3
rd
et al
,
,
,
.
•
1
Department of Radiation Oncology, Scripps Clinic, San Diego,
California, USA.
•
PURPOSE:
•
Evaluate efficacy and toxicity of salvage high-dose-rate brachytherapy
(HDRB) for locally recurrent prostate cancer after definitive radiation
therapy (RT).
•
CONCLUSIONS:
•
Prostate HDRB is an effective salvage modality with relatively
few long-term toxicities.